Related Experiment Video
Updated: Aug 9, 2026

Resurrection of Dormant Daphnia magna: Protocol and Applications
Published on: January 19, 2018
Physiological and reproductive effects of beta adrenergic receptor antagonists in Daphnia magna
Edward M Dzialowski1, Philip K Turner, Bryan W Brooks
1Department of Biological Sciences, University of North Texas, Denton, 76203, USA. edzial@unt.edu
Abstract:
Although pharmaceuticals are increasingly found in surface waters, environmental levels of many of these compounds are not acutely toxic to model test organisms. Prior to conducting appropriate ecological risk assessments of pharmaceuticals, the mode of action-based biomarkers needs to be developed for non-target species. To evaluate toxicity of the beta-adrenergic blockers propranolol and metoprolol on non-target biota, we assessed standard ecotoxicological endpoints after 9 days of subchronic exposure in a transgenerational study with Daphnia magna. On day 9 of exposure, the lowest observed effects concentration (LOEC) for growth were 0.44 mg L(-1) for propranolol and 12 mg L(-1) for metoprolol. Total fecundity LOECs for the 9-day exposure were 0.11 mg L(-1) and 6 mg L(-1) for propranolol and metoprolol, respectively. In addition to typical ecotoxicological endpoints, we evaluated the utility of employing the physiological biomarkers of heart rate and metabolic rate following subchronic and acute exposures to propranolol and metoprolol. Propranolol and metoprolol LOECs for heart rate were 0.055 mg L(-1) and 3.1 mg L(-1), significantly lower than the LOECs for growth and reproduction. At these concentrations, heart rate was significantly lower than the control values for both compounds. Daphnia magna endpoint sensitivity to chronic propranolol and metoprolol exposure was mortality < growth < fecundity < heart rate. Second generation D. magna were less sensitive to both compounds. Responses of the physiological biomarkers heart rate and metabolic activity suggest that propranolol and metoprolol exerts sublethal toxicity to D. magna at lower concentrations than observed in the classical endpoints.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...

